Results 171 to 180 of about 2,327,467 (213)

Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization. [PDF]

NPJ Cardiovasc Health
Zhao JV, Sarsani V, Chen B, Yun H, Hu J, Liang L.   +5 more
europepmc   +1 more source

Dairy Consumption and Risk of Cardiometabolic Diseases: A Prospective Cohort Study of the China Kadoorie Biobank. [PDF]

J Nutr
Kakkoura MG, Wang H, Iona A, Chen Y, Kartsonaki C, Im PK, Millwood IY, Papier K, Yu C, Pei P, Sun D, Yang L, Avery D, Yang X, Yu M, Lv J, Chen J, Li L, Chen Z, Du H, China Kadoorie Biobank Collaborative Group.   +20 more
europepmc   +1 more source

Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases.

J Clin Endocrinol Metab
Swartz AZ, Wood K, Farber-Eger E, Petty A, Silver HJ.   +4 more
europepmc   +1 more source

Obesity and the Risk of Cardiometabolic Diseases

Nature Reviews Cardiology, 2023
The prevalence of obesity has reached pandemic proportions, and now approximately 25% of adults in Westernized countries have obesity. Recognized as a major health concern, obesity is associated with multiple comorbidities, particularly cardiometabolic ...
Adrián Castillo-García, Alejandro Santos-Lozano, Pedro Carrera-Bastos   +2 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Obesity Duration and Cardiometabolic Disease

Arteriosclerosis, Thrombosis, and Vascular Biology, 2023
Cardiovascular disease risk is known to be influenced by both the severity of a risk factor and the duration of exposure (eg, LDL [low-density lipoprotein] cholesterol, tobacco smoke). However, this concept has been largely neglected within the obesity literature. While obesity severity has been closely linked with cardiometabolic diseases, the risk of
Sharnendra K. Sidhu, Jose O. Aleman, Sean P. Heffron   +2 more
openaire   +2 more sources

Mast Cells in Human and Experimental Cardiometabolic Diseases

Nature Reviews Cardiology, 2015
Mast cells, like many other types of inflammatory cell, perform pleiotropic roles in cardiometabolic diseases such as atherosclerosis, abdominal aortic aneurysms, obesity, and diabetes mellitus, as well as complications associated with these diseases ...
Guo-Ping Shi, Ilze Bot, Petri T Kovanen
exaly   +2 more sources

Sleep Deficiency and Cardiometabolic Disease

Sleep Medicine Clinics, 2022
Epidemiologic studies have demonstrated that short sleep duration is associated with an increased risk of cardio-metabolic health outcomes including cardiovascular disease mortality, coronary heart disease, type 2 diabetes mellitus, hypertension, and metabolic syndrome. Experimental sleep restriction studies have sought to explain these findings.
Roo, Killick, Lachlan, Stranks, Camilla M, Hoyos   +2 more
openaire   +4 more sources

MicroRNAs in Cardiometabolic Disease

Current Atherosclerosis Reports, 2011
Defects in homeostatic regulation of cholesterol and fatty acids are associated with major cardiometabolic risk factors that are prevalent in type 2 diabetes and atherosclerotic cardiovascular disease. Regulatory input is found at many levels; however, recent findings have revealed pivotal roles for small non-coding RNAs (microRNAs) of the endogenous ...
openaire   +2 more sources

Cardiometabolic Disorders in Psoriatic Disease

Current Rheumatology Reports, 2017
Patients with psoriasis and psoriatic arthritis, collectively termed psoriatic disease (PsD), are at an increased risk of developing cardiovascular diseases (CVD). The purpose if this manuscript is to review recent evidence about the epidemiology and underlying mechanisms of CVD in psoriatic patients and approaches to improve the management of these ...
Curtis, Sobchak, Lihi, Eder
openaire   +2 more sources